Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD

M. Shameem, Q. Hussain, A. Ahmad (Aligarh, India)

Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Session: Tobacco dependence and respiratory disease
Session type: Thematic Poster Session
Number: 1054
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shameem, Q. Hussain, A. Ahmad (Aligarh, India). Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD. Eur Respir J 2012; 40: Suppl. 56, 1054

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The importance of measuriing exhaled carbon monoxide in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003

Carbon monoxide levels in exhaled air do not correlate with airway responsiveness after antigenic bronchoprovocation of asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 413s
Year: 2003

Methacholine-induced bronchoconstriction does not modify exhaled carbon monoxide level in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 165s
Year: 2001

Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002



Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

Increase of exhaled carbon monoxide in subjects with non-controlled asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Exhaled carbon monoxide levels during treatment of acute asthma
Source: Eur Respir J 2001; 17: 1336
Year: 2001


Carbon monoxide pollution is associated with decreased lung function in asthmatic adults
Source: Eur Respir J 2010; 35: 266-272
Year: 2010



The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006

Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015


Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD
Source: International Congress 2017 – Smoking and health hazards
Year: 2017


Measurement of exhaled gases in chronic airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Exhaled carbon monoxide in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO)
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004